Hyperlipidemia secondary to acitretin therapy for lamellar ichthyosis associated with a NIPAL4 mutation improves on a plant-based diet and relapses on a standard Western diet

Clin Nutr ESPEN. 2018 Apr:24:54-57. doi: 10.1016/j.clnesp.2018.01.070. Epub 2018 Feb 23.

Abstract

Oral retinoids are commonly prescribed for many dermatological conditions and may induce hyperlipidemia. We document the case of a 35-year-old man taking acitretin for congenital lamellar ichthyosis associated with a homozygous deleterious mutation in NIPAL4 who developed retinoid-induced hyperlipidemia that responded dramatically to a whole-food plant-based (WFPB) diet. On presentation, his diet consisted of chicken, fish, low fat meats and dairy, grains, and some fruits and vegetables. He then adopted a WFPB diet without making changes to his medications. His serum lipid levels dropped and his exercise capacity improved. Five months later, after discontinuing the plant-based diet and returning to his baseline diet, his hyperlipidemia returned and persisted despite adjustments to his medications. After a year and a half, the patient again adopted a plant-based diet and his lipid levels fell sharply again. A WFPB diet helped improve and control serum lipid levels in a patient with retinoid-induced hyperlipidemia. Future interventions should focus on ways to help patients successfully adopt and maintain a WFPB diet, as increased adherence to a healthy lifestyle is associated with greater health benefits.

Keywords: Acitretin; Congenital ichthyosis; Hyperlipidemia; Plant-based diet.

Publication types

  • Case Reports

MeSH terms

  • Acitretin / adverse effects
  • Acitretin / therapeutic use*
  • Adult
  • Combined Modality Therapy
  • Diet, Vegan*
  • Diet, Western / adverse effects*
  • Humans
  • Hyperlipidemias / chemically induced*
  • Hyperlipidemias / diet therapy
  • Ichthyosis, Lamellar / genetics
  • Ichthyosis, Lamellar / physiopathology
  • Ichthyosis, Lamellar / therapy*
  • Keratolytic Agents / adverse effects
  • Keratolytic Agents / therapeutic use*
  • Male
  • Mutation
  • Patient Education as Topic
  • Receptors, Cell Surface / genetics*
  • Recurrence
  • Treatment Outcome

Substances

  • Keratolytic Agents
  • NIPAL4 protein, human
  • Receptors, Cell Surface
  • Acitretin